Long-term management of an idiopathic gingival fibromatosis patient with the primary dentition.

Abstract

Gingival fibromatosis is usually seen as an isolated finding or occasionally in association with other features as part of a syndrome. The combination of gingival enlargement, hypertrichosis, epilepsy and mental retardation is also a commonly reported syndrome that features gingival fibromatosis. The following report is about a mentally retarded patient who has shown no sign of hypertrichosis, but has been taking phenobarbital as a long-term therapy drug for anti-convulsion. Long-term management of this patient has been carried out from the age of one-and-a-half years to 14 years old. The patient's clinical features, treatment received, histopathologic presentation of gingival fibromatosis and proper management of the condition are discussed.

• Authors: S Kamolmatyakul, S Kietthubthew, O Anusaksathien
• Journal: Pediatric dentistry (Pediatr Dent) 2001 Nov-Dec Vol. 23 Issue 6 Pg. 508-13 ISSN: 0164-1263 [Print] United States
• PMID: 11800453 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anticonvulsants
• Dental Amalgam
• Phenobarbital

Topics

• Anticonvulsants (therapeutic use)
• Crowns
• Dental Amalgam
• Dental Restoration, Permanent
• Diagnosis, Differential
• Female
• Fibromatosis, Gingival (pathology, surgery, therapy)
• Follow-Up Studies
• Gingivectomy
• Humans
• Infant
• Intellectual Disability (complications)
• Mucopolysaccharidoses (diagnosis)
• Phenobarbital (therapeutic use)
• Seizures (drug therapy)
• Syndrome
• Tooth, Deciduous